You just read:

Sorrento and Servier Enter Into Exclusive Worldwide License and Collaboration Agreement for Development and Commercialization of Anti-PD-1 Antibody

News provided by

Sorrento Therapeutics, Inc.

Jul 11, 2016, 09:00 ET